Listed

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NEUROONE MEDICAL TECHNOLOGIES Corp, Reports and events
FiledFormWhat it isAccession number
2024-05-1420:16 ET10-QQuarterly reportPeriod 2024-03-310001213900-24-042948
2024-05-1420:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-042938
2024-03-2613:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-025811
2024-03-1520:30 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-24-023083
2024-02-1321:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-013294
2024-02-1321:05 ET10-QQuarterly reportPeriod 2023-12-310001213900-24-013276
2024-01-2914:00 ETDEF 14AProxy statementPeriod 2024-03-140001213900-24-007191
2023-12-1521:39 ET10-KAnnual reportPeriod 2023-09-300001213900-23-096120
2023-12-1421:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-23-095741
2023-12-1113:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-094562
2023-11-1613:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-087723
2023-11-1422:28 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-087126
2023-11-0713:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-084013
2023-08-1420:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-23-067061
2023-08-1420:06 ET10-QQuarterly reportPeriod 2023-06-300001213900-23-067019
2023-07-2720:02 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-060256
2023-05-1220:15 ET10-QQuarterly reportPeriod 2023-03-310001213900-23-039030
2023-05-1120:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-23-038538
2023-03-1720:34 ET8-K5.07 Shareholder vote results0001213900-23-021037
2023-03-1022:00 ET8-K7.01 Regulation FD disclosure0001213900-23-019237
2023-02-1421:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-23-011512
2023-02-1321:15 ET10-QQuarterly reportPeriod 2022-12-310001213900-23-010739
2023-01-2713:30 ETDEF 14AProxy statementPeriod 2023-03-160001213900-23-005481
2023-01-1321:15 ET8-K8.01 Other events0001213900-23-002798
2022-12-2214:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-22-081976
2022-12-2201:52 ET10-KAnnual reportPeriod 2022-09-300001213900-22-081897
2022-12-1621:16 ET8-K5.08 Item not in the standard list; 9.01 Financial statements and exhibits0001213900-22-080515
2022-10-2513:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-065984
2022-09-1412:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-22-055776
2022-08-1120:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-22-046936
2022-08-1120:30 ET10-QQuarterly reportPeriod 2022-06-300001213900-22-046902
2022-08-0313:34 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-044311
2022-06-0220:05 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-030944
2022-05-3120:31 ET10-K/AAnnual report, amendedPeriod 2021-09-300001213900-22-030420
2022-05-1620:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-027182
2022-05-1220:26 ET10-QQuarterly reportPeriod 2022-03-310001213900-22-025966
2022-05-1220:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-22-025953
2022-04-2912:00 ETDEF 14AProxy statementPeriod 2022-05-310001213900-22-022526
2022-03-2520:45 ET8-K8.01 Other events0001213900-22-015203
2022-02-1421:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-22-007517
2022-02-1421:02 ET10-QQuarterly reportPeriod 2021-12-310001213900-22-007486
2022-02-0421:10 ET8-K5.02 Departure or appointment of officers or directors0001213900-22-005501
2021-12-1521:31 ET10-KAnnual reportPeriod 2021-09-300001213900-21-065463
2021-12-1513:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-21-065344
2021-10-1413:00 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-052752
2021-10-0420:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001013762-21-000094
2021-09-0720:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-21-046892
2021-08-1312:15 ET10-QQuarterly reportPeriod 2021-06-300001213900-21-042294
2021-08-1312:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-21-042291
2021-06-2420:15 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001213900-21-033970

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.